Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation Mohamed-Eslam F. MohamedSheryl TruemanPatrick Marroum Research Article Open access 25 October 2019 Article: 108
Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib Michael MurrayTina B. GillaniPramod C. Nair Research Article 21 October 2019 Article: 107
Optimization of Cancer Treatment in the Frequency Domain Pascal SchulthessVivi RottschäferPiet H. van der Graaf Research Article Open access 11 September 2019 Article: 106
Retrospective Analysis of Bioanalytical Method Validation Approaches in Biosimilar Biological Product Development O. N. ObianomTheingi M. ThwayI. Zineh Research Article 11 September 2019 Article: 105
Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies Mohsin AliJutta Tinson behalf of LENA Consortium Research Article 04 September 2019 Article: 104
How Transporters Have Changed Basic Pharmacokinetic Understanding Leslie Z. BenetChristine M. BowmanJasleen K. Sodhi Tutorial 03 September 2019 Article: 103
On the Comparison of Methods in Analyzing Bounded Outcome Score Data Chuanpu Hu Commentary 26 August 2019 Article: 102
Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay Noriko IwamotoMegumi TakanashiAkinobu Hamada Research Article 20 August 2019 Article: 101